100 mg
Trade Name
Xadago
Film-coated tablet
Request Type
New Registration
Drug Type
NCE
Approval Date
SFDA Approved Use
Indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.